Telomere Length Defines the Cardiomyocyte Differentiation Potency of Mouse Induced Pluripotent Stem Cells

Stem Cells

Volumn 35, Issue 2, 2017, Pages 362-373

  Aguado, Tania ^a   Gutiérrez, Francisco J ^a   Aix, Esther ^a   Schneider, Ralph P ^b   Giovinazzo, Giovanna ^a   Blasco, María A ^b   Flores, Ignacio ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Centro Nacional de Investigaciones Oncológicas   (Spain)

Author keywords

Ascorbic acid; Cardiomyocytes; Extracellular matrix; Induced pluripotent stem cells; Telomere length

Indexed keywords

ASCORBIC ACID; TELOMERASE; TELOMERIC REPEAT BINDING FACTOR 1; COLLAGEN;

ANIMAL CELL; ARTICLE; CARDIAC MUSCLE CELL; CELL COMPOSITION; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CONTROLLED STUDY; ECTODERM; EMBRYO; EMBRYOID BODY; ENDODERM; IN VITRO SELECTION; INDUCED PLURIPOTENT STEM CELL; MESODERM; MOUSE; NONHUMAN; PROTEIN EXPRESSION; TELOMERE; TELOMERE LENGTH; ANIMAL; CELL PROLIFERATION; CELL SIZE; CYTOLOGY; DRUG EFFECTS; METABOLISM; TELOMERE HOMEOSTASIS;

ANIMALS; ASCORBIC ACID; CELL DIFFERENTIATION; CELL LINEAGE; CELL PROLIFERATION; CELL SIZE; COLLAGEN; EMBRYOID BODIES; INDUCED PLURIPOTENT STEM CELLS; MICE; MYOCYTES, CARDIAC; TELOMERE HOMEOSTASIS;

EID: 84989283200     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2497     Document Type: Article

References (70)

1. Mozaffarian D, Benjamin EJ, Go AS et al. Heart disease and stroke statistics–2015 update: A report from the American Heart Association. Circulation 2015;131:e29–322.
2. von Lueder TG, Krum H. New medical therapies for heart failure. Nat Rev Cardiol 2015;12:730–740.
3. Kikuchi K, Poss KD. Cardiac regenerative capacity and mechanisms. Annu Rev Cell Dev Biol 2012;28:719–741.
4. van Berlo JH, Molkentin JD. An emerging consensus on cardiac regeneration. Nat Med 2014;20:1386–1393.
5. Goumans MJ, Maring JA, Smits AM. A straightforward guide to the basic science behind cardiovascular cell-based therapies. Heart 2014;100:1153–1157.
6. Pavo N, Charwat S, Nyolczas N et al. Cell therapy for human ischemic heart diseases: Critical review and summary of the clinical experiences. J Mol Cell Cardiol 2014;75:12–24.
7. Hsiao LC, Carr C, Chang KC et al. Stem cell-based therapy for ischemic heart disease. Cell Transplant 2013;22:663–675.
8. Sinnecker D, Goedel A, Laugwitz KL et al. Induced pluripotent stem cell-derived cardiomyocytes: A versatile tool for arrhythmia research. Circ Res 2013;112:961–968.
9. Chong JJ, Murry CE. Cardiac regeneration using pluripotent stem cells–progression to large animal models. Stem Cell Res 2014;13:654–665.
10. Lalit PA, Hei DJ, Raval AN et al. Induced pluripotent stem cells for post-myocardial infarction repair: Remarkable opportunities and challenges. Circ Res 2014;114:1328–1345.
11. Mummery CL, Lee RT. Is heart regeneration on the right track? Nat Med 2013;19:412–413.
12. Funakoshi S, Miki K, Takaki T et al. Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes. Sci Rep 2016;6:19111.
13. Dimmeler S, Ding S, Rando TA et al. Translational strategies and challenges in regenerative medicine. Nat Med 2014;20:814–821.
14. Kaichi S, Hasegawa K, Takaya T et al. Cell line-dependent differentiation of induced pluripotent stem cells into cardiomyocytes in mice. Cardiovasc Res 2010;88:314–323.
15. Cahan P, Daley GQ. Origins and implications of pluripotent stem cell variability and heterogeneity. Nat Rev Mol Cell Biol 2013;14:357–368.
16. Chan SW, Blackburn EH. New ways not to make ends meet: Telomerase, DNA damage proteins and heterochromatin. Oncogene 2002;21:553–563.
17. Marion RM, Strati K, Li H et al. Telomeres acquire embryonic stem cell characteristics in induced pluripotent stem cells. Cell Stem Cell 2009;4:141–154.
18. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007;131:861–872.
19. Wang F, Yin Y, Ye X et al. Molecular insights into the heterogeneity of telomere reprogramming in induced pluripotent stem cells. Cell Res 2012;22:757–768.
20. Liu L, Bailey SM, Okuka M et al. Telomere lengthening early in development. Nat Cell Biol 2007;9:1436–1441.
21. Pucci F, Gardano L, Harrington L. Short telomeres in ESCs lead to unstable differentiation. Cell Stem Cell 2013;12:479–486.
22. Schneider RP, Garrobo I, Foronda M et al. TRF1 is a stem cell marker and is essential for the generation of induced pluripotent stem cells. Nat Commun 2013;4:1946.
23. Maltsev VA, Wobus AM, Rohwedel J et al. Cardiomyocytes differentiated in vitro from embryonic stem cells developmentally express cardiac-specific genes and ionic currents. Circ Res 1994;75:233–244.
24. Cao N, Liu Z, Chen Z et al. Ascorbic acid enhances the cardiac differentiation of induced pluripotent stem cells through promoting the proliferation of cardiac progenitor cells. Cell Res 2012;22:219–236.
25. Flores I, Canela A, Vera E et al. The longest telomeres: A general signature of adult stem cell compartments. Genes Dev 2008;22:654–667.
26. Layland J, Cave AC, Warren C et al. Protection against endotoxemia-induced contractile dysfunction in mice with cardiac-specific expression of slow skeletal troponin I. FASEB J 2005;19:1137–1139.
27. Rajala K, Pekkanen-Mattila M, Aalto-Setala K. Cardiac differentiation of pluripotent stem cells. Stem Cells Int 2011;2011:383709.
28. Kathiriya IS, Nora EP, Bruneau BG. Investigating the transcriptional control of cardiovascular development. Circ Res 2015;116:700–714.
29. Boland MJ, Nazor KL, Loring JF. Epigenetic regulation of pluripotency and differentiation. Circ Res 2014;115:311–324.
30. Valamehr B, Jonas SJ, Polleux J et al. Hydrophobic surfaces for enhanced differentiation of embryonic stem cell-derived embryoid bodies. Proc Natl Acad Sci USA 2008;105:14459–14464.
31. Coucouvanis E, Martin GR. Signals for death and survival: A two-step mechanism for cavitation in the vertebrate embryo. Cell 1995;83:279–287.
32. Li S, Harrison D, Carbonetto S et al. Matrix assembly, regulation, and survival functions of laminin and its receptors in embryonic stem cell differentiation. J Cell Biol 2002;157:1279–1290.
33. Murray P, Edgar D. Regulation of programmed cell death by basement membranes in embryonic development. J Cell Biol 2000;150:1215–1221.
34. Zhang J, Liu G, Ruan Y et al. Dax1 and Nanog act in parallel to stabilize mouse embryonic stem cells and induced pluripotency. Nat Commun 2014;5:5042.
35. Niakan KK, Ji H, Maehr R et al. Sox17 promotes differentiation in mouse embryonic stem cells by directly regulating extraembryonic gene expression and indirectly antagonizing self-renewal. Genes Dev 2010;24:312–326.
36. Kanai-Azuma M, Kanai Y, Gad JM et al. Depletion of definitive gut endoderm in Sox17-null mutant mice. Development 2002;129:2367–2379.
37. Kwon GS, Fraser ST, Eakin GS et al. Tg(Afp-GFP) expression marks primitive and definitive endoderm lineages during mouse development. Dev Dyn 2006;235:2549–2558.
38. Coucouvanis E, Martin GR. BMP signaling plays a role in visceral endoderm differentiation and cavitation in the early mouse embryo. Development 1999;126:535–546.
39. Poschl E, Schlotzer-Schrehardt U, Brachvogel B et al. Collagen IV is essential for basement membrane stability but dispensable for initiation of its assembly during early development. Development 2004;131:1619–1628.
40. Li X, Chen Y, Scheele S et al. Fibroblast growth factor signaling and basement membrane assembly are connected during epithelial morphogenesis of the embryoid body. J Cell Biol 2001;153:811–822.
41. Smyth N, Vatansever HS, Murray P et al. Absence of basement membranes after targeting the LAMC1 gene results in embryonic lethality due to failure of endoderm differentiation. J Cell Biol 1999;144:151–160.
42. Rozario T, DeSimone DW. The extracellular matrix in development and morphogenesis: A dynamic view. Dev Biol 2010;341:126–140.
43. Sato H, Takahashi M, Ise H et al. Collagen synthesis is required for ascorbic acid-enhanced differentiation of mouse embryonic stem cells into cardiomyocytes. Biochem Biophys Res Commun 2006;342:107–112.
44. Discher DE, Mooney DJ, Zandstra PW. Growth factors, matrices, and forces combine and control stem cells. Science 2009;324:1673–1677.
45. Huang Y, Liang P, Liu D et al. Telomere regulation in pluripotent stem cells. Protein Cell 2014;5:194–202.
46. Marion RM, Blasco MA. Telomere rejuvenation during nuclear reprogramming. Curr Opin Genet Dev 2010;20:190–196.
47. Marion RM, Strati K, Li H et al. A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 2009;460:1149–1153.
48. Garrobo I, Marion RM, Dominguez O et al. Genome-wide analysis of in vivo TRF1 binding to chromatin restricts its location exclusively to telomeric repeats. Cell Cycle 2014;13:3742–3749.
49. Bratt-Leal AM, Carpenedo RL, McDevitt TC. Engineering the embryoid body microenvironment to direct embryonic stem cell differentiation. Biotechnol Prog 2009;25:43–51.
50. Engler AJ, Sen S, Sweeney HL et al. Matrix elasticity directs stem cell lineage specification. Cell 2006;126:677–689.
51. Watt FM, Huck WT. Role of the extracellular matrix in regulating stem cell fate. Nat Rev Mol Cell Biol 2013;14:467–473.
52. Gattazzo F, Urciuolo A, Bonaldo P. Extracellular matrix: A dynamic microenvironment for stem cell niche. Biochim Biophys Acta 2014;1840:2506–2519.
53. Lockhart M, Wirrig E, Phelps A et al. Extracellular matrix and heart development. Birth Defects Res A Clin Mol Teratol 2011;91:535–550.
54. Narazaki G, Uosaki H, Teranishi M et al. Directed and systematic differentiation of cardiovascular cells from mouse induced pluripotent stem cells. Circulation 2008;118:498–506.
55. Cheng P, Andersen P, Hassel D et al. Fibronectin mediates mesendodermal cell fate decisions. Development 2013;140:2587–2596.
56. Li L, Arman E, Ekblom P et al. Distinct GATA6- and laminin-dependent mechanisms regulate endodermal and ectodermal embryonic stem cell fates. Development 2004;131:5277–5286.
57. Turner DA, Trott J, Hayward P et al. An interplay between extracellular signalling and the dynamics of the exit from pluripotency drives cell fate decisions in mouse ES cells. Biol Open 2014;3:614–626.
58. Tropepe V, Hitoshi S, Sirard C et al. Direct neural fate specification from embryonic stem cells: A primitive mammalian neural stem cell stage acquired through a default mechanism. Neuron 2001;30:65–78.
59. Smukler SR, Runciman SB, Xu S et al. Embryonic stem cells assume a primitive neural stem cell fate in the absence of extrinsic influences. J Cell Biol 2006;172:79–90.
60. Park J, Cho CH, Parashurama N et al. Microfabrication-based modulation of embryonic stem cell differentiation. Lab Chip 2007;7:1018–1028.
61. Hwang YS, Chung BG, Ortmann D et al. Microwell-mediated control of embryoid body size regulates embryonic stem cell fate via differential expression of WNT5a and WNT11. Proc Natl Acad Sci USA 2009;106:16978–16983.
62. Lindstrom S, Mori K, Ohashi T et al. A microwell array device with integrated microfluidic components for enhanced single-cell analysis. Electrophoresis 2009;30:4166–4171.
63. Karp JM, Yeh J, Eng G et al. Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip 2007;7:786–794.
64. Moon SH, Ju J, Park SJ et al. Optimizing human embryonic stem cells differentiation efficiency by screening size-tunable homogenous embryoid bodies. Biomaterials 2014;35:5987–5997.
65. Burridge PW, Anderson D, Priddle H et al. Improved human embryonic stem cell embryoid body homogeneity and cardiomyocyte differentiation from a novel V-96 plate aggregation system highlights interline variability. Stem Cells 2007;25:929–938.
66. Mohr JC, Zhang J, Azarin SM et al. The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells. Biomaterials 2010;31:1885–1893.
67. Huang J, Wang F, Okuka M et al. Association of telomere length with authentic pluripotency of ES/iPS cells. Cell Res 2011;21:779–792.
68. Laflamme MA, Murry CE. Regenerating the heart. Nat Biotechnol 2005;23:845–856.
69. Sahara M, Santoro F, Chien KR. Programming and reprogramming a human heart cell. EMBO J 2015;34:710–738.
70. Burridge PW, Sharma A, Wu JC. Genetic and epigenetic regulation of human cardiac reprogramming and differentiation in regenerative medicine. Annu Rev Genet 2015;49:461–484.